Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)

BACKGROUND: Sodium-glucose cotransporter 2 inhibitors reduce the risk of heart failure hospitalization and cardiovascular death in patients with heart failure and reduced ejection fraction (HFrEF). However, their effects on cardiac structure and function in HFrEF are uncertain. METHODS: We designed...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation
Hauptverfasser: Lee, Matthew M.Y., Brooksbank, Katriona J.M., Wetherall, Kirsty, Mangion, Kenneth, Roditi, Giles, Campbell, Ross T., Berry, Colin, Chong, Victor, Coyle, Liz, Docherty, Kieran F., Dreisbach, John G., Labinjoh, Catherine, Lang, Ninian N., Lennie, Vera, McConnachie, Alex, Murphy, Clare L., Petrie, Colin J., Petrie, John R., Speirits, Iain A., Sourbron, Steven, Welsh, Paul, Woodward, Rosemary, Radjenovic, Aleksandra, Mark, Patrick B., McMurray, John J.V., Jhund, Pardeep S., Petrie, Mark C., Sattar, Naveed
Format: Artigo
Sprache:Inglês
Veröffentlicht: Lippincott Williams & Wilkins 2020
Schlagworte:
Original Research Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7864599/
https://ncbi.nlm.nih.gov/pubmed/33186500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.120.052186
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge